Connection

Jonathan Douxfils to Aged

This is a "connection" page, showing publications Jonathan Douxfils has written about Aged.
Connection Strength

0.096
  1. Antibody titres decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021 Dec; 10(1):1495-1498.
    View in: PubMed
    Score: 0.017
  2. Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses. 2021 07 14; 13(7).
    View in: PubMed
    Score: 0.017
  3. Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021 Sep; 27(9):1351.e5-1351.e7.
    View in: PubMed
    Score: 0.017
  4. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients. Clin Chem Lab Med. 2021 04 27; 59(5):e179-e183.
    View in: PubMed
    Score: 0.016
  5. Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins. J Med Virol. 2021 04; 93(4):2262-2269.
    View in: PubMed
    Score: 0.016
  6. An original multiplex method to assess five different SARS-CoV-2 antibodies. Clin Chem Lab Med. 2021 04 27; 59(5):971-978.
    View in: PubMed
    Score: 0.004
  7. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021 02; 93(2):803-811.
    View in: PubMed
    Score: 0.004
  8. Prospective and comparative study of paroxysmal nocturnal hemoglobinuria patients treated or not by eculizumab: Focus on platelet extracellular vesicles. Medicine (Baltimore). 2019 Jul; 98(27):e16164.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.